Blueprint For Evaluating And Mitigating Drug Risk
On Sept. 30, 2009, the U.S. Food and Drug Administration released a draft of its Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments...To view the full article, register now.
Already a subscriber? Click here to view full article